Full-Time

SEND Data Specialist

Posted on 11/1/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Montreal, QC, Canada

In Person

Category
Data & Analytics (2)
,
Requirements
  • BS/MS degree, preferably in a scientific or technical discipline; equivalent combination of education, related experience and/or certified training
  • Intermediate computer skills including Microsoft Office suite and project management tools
  • English proficiency required read and interpret documents such as safety rules, operating and maintenance instructions, and procedure manuals, and write routine reports and correspondence
  • Demonstrates excellent oral and written communications and teamwork skills for interaction with a multidisciplinary project team
  • Speak effectively before groups of customers or employees of the organization
  • Intermediate maths skills as used in the life sciences industry, algebra, and statistics
  • Diagnosing, tracking and solving system problems
  • Demonstrates strong support for customers and team members, carefully follows verbal and written instruction and contributes independently or as team member
  • Positive customer service orientation, with a quality oriented work ethic
  • Development and utilization of written procedures, checklists and test plans required
  • Key skills include strong computer and writing skills, attention to detail, excellent interpersonal and organizational skills
Responsibilities
  • Ensure preparation of SEND datasets are submission ready, including the harmonization of study data from multiple data sources, including such as sponsors, Provantis, LIMS, test sites, and/or other testing facilities
  • Perform a quality control review on the resulting SEND dataset to ensure the data is equivalent to that presented in the study report
  • Resolve system errors, disruptions, and concerns as they relate to protocol management (in conjunction with IT staff, as applicable) and communicates resolutions to the appropriate departments
  • Develop and utilizes written standard operating procedures based on information security guidelines, regulatory requirements, and industry best practices
  • Maintain technical documentation in support of all these duties
  • Respond to internal/external audit findings and contribute to corrective actions as needed
  • Assist in providing SEND system training and maintaining a robust system training program
Desired Qualifications
  • 3+ years experience with SEND in a GLP pre-clinical environment preferred
  • Experience in a global role in a global healthcare services company preferred
  • French language requirement for Quebec operations (context: Altasciences strives to provide a French work environment; essential for Employee Experience Consultant role)

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech/pharma consolidation demand for single-vendor early-phase development solutions increases.
  • 3D tissue technology adoption reduces animal testing costs and accelerates regulatory approval timelines.
  • Geographic footprint and participant database enable rapid enrollment for mid-size biopharma sponsors.

What critics are saying

  • Novo Holdings divesting Altasciences signals poor financial performance and operational cutbacks.
  • Charles River aggressive pricing on integrated packages captures 20% mid-size biopharma contracts.
  • AI-driven preclinical platforms from Insilico Medicine displace traditional animal safety pharmacology testing.

What makes Altasciences unique

  • Integrated CRO/CDMO spanning preclinical safety testing through Phase IV bioanalysis and manufacturing.
  • 9 North American facilities with 500,000+ participant database conducting 285+ trials annually.
  • VoxCell partnership integrates 3D tissue technology for human-relevant preclinical testing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Company News

GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE